Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03305497 · ClinicalTrials.gov registry record
Piloting a Naloxone Intervention in Philadelphia
A clinical trial, sponsored by Drexel University.
- Completed
- Registry status
- 110
- Enrollment target
NCT03305497: Completed study, sponsored by Drexel University.
NCT03305497 is a clinical trial that has completed, run by Drexel University. The registered enrollment target is 110 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03305497 has completed, sponsored by Drexel University.
- COMPLETED
- Registry status
- 110 participants
- Enrollment target
Study Summary
The escalating opioid overdose epidemic is one of the most serious public health problems confronting the U.S. Death due to drug overdose is a significant and rising cause of mortality and morbidity in Philadelphia. While naloxone is increasingly accessible to combat opioid overdoses, new responses to delivering naloxone to overdose events are needed. The proposed pilot project, to be conducted in Philadelphia, will pursue three specific aims: 1) Identify barriers and facilitators of acceptance and use of a smartphone-based naloxone intervention; 2) Pilot test the implementation of the intervention among 55 non-medical opioid users and 55 community members; 3) Synthesize knowledge acquired in Aims 1 and 2 to be used in a subsequent R01 study to conduct a large-scale, multi-site implementation trial.
Primary Outcome
Will persons equipped with the mobile phone app signal overdoses and/or respond to overdoses when signaled.
Interventions
- BEHAVIORAL Mobile Phone Application
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2018-10-23 |
| Est. Completion | 2021-05-31 |
What the finished NCT03305497 record still lists
NCT03305497 is an observational study that tracks outcomes without assigning an intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Mobile Phone Application is the first listed.
NCT03305497 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03305497 about?
NCT03305497 is a clinical study titled "Piloting a Naloxone Intervention in Philadelphia". The escalating opioid overdose epidemic is one of the most serious public health problems confronting the U.S. Death due to drug overdose is a significant and rising cause of mortality and morbidity in Philadelphia. While naloxone is increasingly accessible to combat opioid overdoses, new responses ...
What is the current status of trial NCT03305497?
This trial is currently completed. The enrollment target is 110 participants. The study started on 2018-10-23. Estimated completion is 2021-05-31.
What interventions are being tested in trial NCT03305497?
The interventions under investigation include: Mobile Phone Application (BEHAVIORAL).
Who is sponsoring clinical trial NCT03305497?
This trial is sponsored by Drexel University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI